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Abstract
Purpose To assess the association of peritumoral brain edema (PTBE) with postoperative outcome in old (≥ 80 years) 
meningioma patients.
Methods All supratentorial meningioma patients (≥ 80 years old) who underwent surgery between 2010 and 2018 were 
retrospectively identified. Patients were classified into poor (≤ 40), intermediate (50–70), or good (≥ 80) preoperative 
Karnofsky Performance Status (KPS) subgroups. Outcome was evaluated at 3 months and at last follow-up within the first 
year after surgery, and categorized as improved, stable, or deteriorated. Three-dimensional volumetric assessment of tumor 
and PTBE volume was conducted. Volumes were categorized as small (< 10  cm3), medium (10–50  cm3), large (> 50  cm3).
Results Seventy-two patients (mean age 83 ± 3 years, median 83; median follow-up 3 years) were included. The mean tumor 
volume was 39 ± 31  cm3 (median 27), and mean PTBE volume was 57 ± 79  cm3 (median 27). The mean preoperative KPS 
and at last follow-up was 58 ± 16 (median 60) and 59 ± 30 (median 70). Thirty-three patients were classified as improved, 16 
as stable, and 23 deteriorated; eleven patients died within the first year. Large PTBE volume was more common for patients 
with poor preoperative status (p = 0.001). However, patients with large PTBE and poor preoperative status improved most 
frequently following surgery (p = 0.037 at 3 months, p = 0.074 at last follow-up). Large PTBE volume was not associated 
with treatment-associated complications (p = 0.538) or mortality (p = 0.721). A decision support tool to predict outcome 
was developed (p = 0.038).
Conclusion Elderly patients with large PTBE volumes usually had a poor preoperative performance status, but appeared to 
benefit most often from surgery.
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Introduction
Elderly patients are considered to be more prone to treat-
ment-related morbidity after neurosurgery [11]. Due to the 
demographic developments, there has been increasing inter-
est in the clinical outcome and identification of prognostic 
factors in elderly (≥ 80 years old) meningioma patients [1–3, 
7, 9, 13].
Meningioma-associated symptoms are often caused by 
the peritumoral brain edema (PTBE). However, data on 
the influence of PTBE on patients’ outcome—especially 
in an elderly patient population—are limited. In prior stud-
ies, PTBE has generally been associated with poor surgical 
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outcomes [4–8, 10, 12, 14–16]. Given that only few of 
the previous studies have focused on elderly meningioma 
patients, our aim was to assess whether PTBE affects surgi-
cal outcome of this fragile and rapidly growing patient group 
[4, 5, 7, 10, 12]. To this end, we evaluated the association of 
PTBE with postoperative morbidity and mortality, consider-
ing the tumor location and patients’ preoperative status as 
possible confounders. We hypothesized that larger PTBE 
volumes are associated with poor surgical outcome in very 
old (≥ 80 years old) meningioma patients [4, 7, 10, 12]. 
Furthermore, we aimed to introduce an easy-to-use classi-
fication system and preliminary patient-centered decision 
support tool for improving preoperative patient counseling 
and estimating postoperative outcome.
Methods
Patients
All consecutive patients with histologically-confirmed 
supratentorial meningioma, who had undergone resection 
between 2010 and 2018, were retrospectively identified. The 
inclusion criteria were: (1) patient’s age ≥ 80 years old at 
surgery, (2) clinical follow-up data (within 12 postoperative 
months), and (3) preoperative magnetic resonance imaging 
(MRI). Patients who had undergone surgery for tumor recur-
rences were excluded. The study protocol was approved by 
the institutional review board.
Clinical data
Clinical data were extracted from the electronic patient 
records. The retrieved data included the following 
information: patient characteristics (e.g. age at surgery, sex, 
tumor location, etc.), histopathology, and surgery-associated 
morbidity. The patients’ pre- and postoperative performance 
status were assessed by the Karnofsky Performance Scale 
(KPS). Patients were classified into three subgroups based 
on their preoperative KPS: poor (KPS ≤ 40), intermediate 
(KPS 50–70), and good (KPS ≥ 80) status. Histopathologi-
cal tumor grading followed the World Health Organization 
(WHO) classification system [9].
Magnetic resonance imaging
When multiple meningiomas were present, only the tumor 
for which the initial resection was performed was con-
sidered in the analyses. Maximum diameters were meas-
ured on the T1 + contrast sequences. Three-dimensional 
volumetric assessments of tumor and PTBE volumes were 
conducted by importing the data to the neuronavigation 
(Brainlab  Elements®, Brainlab AG, Germany). Volumes 
were then delineated and calculated via the semi-automatic 
and integrated  SmartBrush® function. The tumor volume 
was calculated based on the T1 + contract sequences (slice 
thickness 1 mm) (Fig. 1), and the PTBE volume was addi-
tionally delineated by the fused T2-sequences (slice thick-
nesses ranged from 1 to 5 mm). The tumor’s dural tail was 
not included for measurements. An edema index (EI) was 
calculated as the ratio between tumor and edema volume.
Follow‑up
According to the standardized follow-up protocol, patients are 
routinely scheduled for a 2- to 3-month postoperative follow-
up visit. Afterwards, WHO grade 1 patients usually have 
follow-up brain MRIs at 2, 5 and 10 years. The WHO grade 2 
Fig. 1  Tumor and PTBE volume measurements
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and 3 patients, as well as patients with partial resection, have 
annual follow-up MRIs for up to 5 years.
The primary outcome measure was the KPS score at 3 
months and at last available follow-up within the first year 
(either at 3, 6 or 12 months after surgery). The secondary out-
come measures were the treatment-associated mortality and 
morbidity. The date of death was retrieved from the patient 
record system; surgery/tumor-related mortality was assessed 
within the first twelve postoperative months. If a patient died 
within the first year, the postoperative KPS was recorded as 
“0” for the corresponding follow-up date. Treatment-asso-
ciated morbidity was classified into major (i.e. intracerebral 
hemorrhage, hemiparesis/new neurological deficits, pneu-
monia, pulmonary embolism) and minor complications (i.e. 
wound infection, cerebrospinal fluid fistula, urinary tract 
infection).
Decision support tool
A scoring system was applied to create a simple tool for 
improving preoperative patient counseling and decision-mak-
ing. Good, intermediate, and poor preoperative status (KPS) 
corresponded to 1, 2, and 3 points, respectively. Tumor and 
PTBE volumes were categorized as small (< 10  cm3), medium 
(10–50  cm3), and large (> 50  cm3); this arbitrary categori-
zation was agreed by three study neurosurgeons prior to any 
statistical analyses. Small, medium, and large PTBE volumes 
corresponded to 1, 2, and 3 points, respectively. The scores 
of both were then added to a final score ranging from 2 to 6 
points. Based on these sum scores, patients with a total score 
of 2 points were classified as Class A, patients with 3–4 points 
as Class B, and patients with 5–6 points as Class C (Table 1).
Statistics
The patients’ sex, tumor location, WHO grade, and complica-
tions were assessed as categorical values. Age and volume-
based parameters were assessed as continuous, and outcome 
(i.e. KPS changes between pre- and postoperative status) was 
categorized as improved, stable, or deteriorated. All variables 
were tested for normality. The correlation analyses (Chi-
squared for categorical parameters, Spearman’s correlation for 
continuous parameters, Kruskal–Wallis test for group analy-
ses) were conducted using SPSS Statistics Version 24 (IBM 
Cooperation, USA). The significance level was p ≤ 0.05.
Results
Patients
Four patients were excluded due to the lack of preoperative 
MRI data. Therefore, the study population consisted of 72 
patients (24 males, 48 females). The mean age at surgery 
was 83 ± 3 years old (median 83, range 80 to 96). The mean 
preoperative KPS score was 58 ± 16 (median 60, range 20 
to 100) at the time of admission. Surgical indications were 
neurological symptoms (n = 67), tumor growth (n = 3) on 
follow-up imaging, and unknown (n = 2). The most com-
mon symptoms included a suspicion of meningioma-related 
cognitive decline (n = 29) and motor deficits (n = 15) (Sup-
plementary Table 1).
The preoperative performance status subgroups consisted 
of 18 (25%) poor, 43 (60%) intermediate, and 11 (15%) 
good clinical status patients. The mean preoperative KPS 
scores were 37 ± 6 (median 40, range 20 to 40) for poor, 
61 ± 7 (median 60, range 50 to 70) for intermediate, and 
84 ± 7 (median 80, range 80 to 100) for good clinical status 
patients. The performance status subgroups did not differ in 
age (p = 0.686, Kruskal–Wallis test), sex (p = 0.236, Chi-
squared), WHO grade (p = 0.475, Chi-squared), and location 
(p = 0.396, Chi-squared).
Meningiomas
The meningiomas were most often located on the convex-
ity (39%) and in the olfactory groove (18%). The most fre-
quently compressed brain lobes were the frontal (67%) and 
temporal lobes (19%). In total, 11% of patients had multiple 
intracranial meningiomas. The majority of meningiomas 
(74%) were of WHO grade 1 (Supplementary Table 1).
Follow‑up
All patients (n = 62) who did not die before the first sched-
uled follow-up visit were clinically assessed at least once 
within the first postoperative year (Supplementary Table 2). 
Fifty-three (85%) patients were assessed at 3 months; for 
25 (36%) patients, this was the only postoperative visit dur-
ing the first year. Nineteen (31%) patients were assessed at 
6 months, and 29 (48%) at 12 months. Thirty-three (53%) 
patients were assessed more than once during the first year. 
Overall, the last KPS within the first postoperative year 
was recorded for 35 (49%) patients at 3 months, for seven 
(10%) at 6 months, and for 30 (42%) patients at 12 months 
(Supplementary Table 2). The overall mean follow-up was 
4 ± 3 years (median 3, range 0–9 years). At least one postop-
erative MRI within the first year was available for 42 (58%) 
patients. Complete tumor removal was seen in 33/42 (79%) 
cases.
Morbidity and mortality
Within the first year, 11 (15%) patients died. Ten deaths 
occurred within the first three postoperative months, and 
one patient died 8 months after surgery. According to our 
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records, 34 (47%) patients suffered from postoperative 
complications. Of these, 14 (19%) suffered from major, 
13 (18%) from minor, and seven (10%) patients suffered 
from both types of complications. The most frequent major 
complications were intracerebral hemorrhage (n = 11) and 
pneumonia (n = 7), and major complications were associ-
ated with a deteriorated clinical outcome (KPS decrease) 
at 3-month (p ≤ 0.001, Chi-squared) and at the last fol-
low-up visit within the first year after surgery (p = 0.004, 
Chi-squared). Major complications associated with an 
increased 90-days- (p = 0.003, Chi-squared) and 1-year 
mortality (p = 0.003, Chi-squared). There was no associa-
tion between the patients’ preoperative clinical status and 
the risk of major complications (p = 0.170, Chi-squared).
Postoperative KPS change
The mean postoperative KPS score was 59 ± 30 (median 
70, range 0–100) at the last follow-up visit within the first 
postoperative year. At 3 months, the mean postoperative 
KPS was 57 ± 30 (median 60, range 0–100), including the 
patients who had died. Based on the last available KPS score 
within 12 months, 33 (46%) patients improved, 16 (22%) 
were stable, and 23 (32%) deteriorated. The highest propor-
tion (61%) of patients with KPS improvement was recorded 
for the poor preoperative status subgroup. The intermediate 
and good preoperative status subgroups improved less often 
(47% and 18% of the patients, respectively). Including only 
those patients for whom KPS data was available at 3 months 
after surgery, the improvement was also most frequent in the 
poor status subgroup in comparison to the intermediate and 
good subgroups (63% vs. 13% and 27%). Anecdotally, five 
(7%) patients had a postoperative KPS of 100 at the last fol-
low-up. In patients (n = 23) for whom a KPS was available 
at 3 and 12 months, KPS scores were similar at both visits 
(mean KPS 70 ± 22, median 70, range 30–100 vs. mean KPS 
73 ± 18, median 70, range 30–100; p = 0.088, paired t-test).
Tumor and PTBE volumes
The mean tumor volume was 37 ± 31  cm3 (median 27 
 cm3, range 1 to 141  cm3), and the mean PTBE volume 
was 56 ± 79  cm3 (median 27  cm3, range 0 to 409  cm3), 
resulting in a mean EI of 1:3 (median 1:1) (Table 1). The 
measured volumes correlated (p = 0.001, Spearman’s cor-
relation); in other words, large tumors had large PTBEs. 
The highest proportion of large tumor and PTBE volumes 
(> 50  cm3) were found in poor preoperative status patients 
(KPS ≤ 40), and the PTBE volume was associated with 
the patients’ preoperative status (p = 0.001, Chi-squared) 
(Fig. 2) (Supplementary Table 3a and 3b).
Patients with large tumor and PTBE volumes benefit-
ted (i.e. improved) most frequently from surgery (Sup-
plementary Table 4). Specifically, larger PTBE volumes 
were associated with an improved outcome at 3 months 
after surgery (p = 0.037, Kruskal–Wallis test). At the last 
follow-up visit within the first 12 months after surgery, 
this association did not reach significance (p = 0.074, 
Kruskal–Wallis test). The tumor volume, in contrast, was 
neither associated with the patients’ outcome at 3 months 
Table 1  Decision support tool





 Intermediate (KPS 50–70) 2
 Poor (KPS ≤ 40) 3
PTBE volume Score
 Small (< 10  cm3) 1
 Medium (10–50  cm3) 2





Patient characteristics—all patients (n = 72)
Median age at surgery (range) (years) 83 (80–96)
Median preoperative KPS score (range) 60 (20–100)
Median tumor volume (range)  (cm3) 27 (1–141)
Median PTBE volume (range)  (cm3) 27 (0–409)
Median EI 1:1
Patient characteristics—class A (n = 11)
Median age at surgery (range) (years) 83 (80–86)
Median preoperative KPS score (range) 80 (80–100)
Median tumor volume (range)  (cm3) 16 (7–63)
Median PTBE volume (range)  (cm3) 0 (0–14)
Median EI 1:0
Patient characteristics—class B (n = 30)
Median age at surgery (range) (years) 83 (80–89)
Median preoperative KPS score (range) 60 (30–70)
Median tumor volume (range)  (cm3) 25 (1–107)
Median PTBE volume (range)  (cm3) 4 (0–49)
Median EI: 1:1
Patient characteristics—class C (n = 31)
Median age at surgery (range) (years) 83 (80–96)
Median preoperative KPS score (range) 50 (20–70)
Median tumor volume (range)  (cm3) 38 (3–141)
Median PTBE volume (range)  (cm3) 109 (15–409)
Median EI 1:3
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(p = 0.263, Kruskal–Wallis test) nor at the last follow-
up within the first 12 months (p = 0.106, Kruskal–Wallis 
test). Similarly, the EI did not correlate with outcome at 3 
months (p = 0.115, Kruskal–Wallis test) nor at the last fol-
low-up (p = 0.185, Kruskal–Wallis test). Neither the tumor 
nor PTBE volumes were associated with major complica-
tions (p = 0.241; p = 0.538, Kruskal–Wallis test) or with 
the 90-day (p = 0.672; p = 0.961, Kruskal–Wallis test) and 
1-year mortality (p = 0.667; p = 0.721, Kruskal–Wallis 
test) (Supplementary Table 4).
Neither volumes correlated with age (p = 0.956 and 
p  =  0.433, Spearman’s correlation), sex (p  =  0.738; 
p = 0.327, Kruskal–Wallis test), WHO grade (p = 0.269; 
p  =  0.325, Kruskal–Wallis test), tumor lateralization 
(p = 0.446; p = 0.054, Kruskal–Wallis test), or tumor loca-
tion (p = 0.625; p = 0.313, Kruskal–Wallis test).
Decision support tool
Patients in the Class C had a clinical benefit most often 
(63%) from surgery at 3-months (63% vs. 24% and 27%; 
p = 0.044, Chi-squared) and at last follow-up within the first 
year (65% vs. 37% and 18%; p = 0.038, Chi-squared) com-
pared to those assigned to the Classes B and A (Table 2). 
In other words, Class C patients (i.e. poor KPS and large 
PTBE volume) were much more likely to improve after sur-
gery than Class A patients (i.e. good KPS and small PTBE 
volume) (Table 2, Fig. 3). The mean KPS improvement was 
highest for the Class C patients (Table 2). 
We found no associations between the PTBE volume and 
90-day mortality (p = 0.806, Chi-squared), 1-year mortality 
(p = 0.618, Chi-squared), major complications (p = 0.124, 
Chi-squared) or KPS deterioration (p = 0.326, Chi-squared).
Discussion
The main findings include several novelties: (1) patients 
with large PTBE volumes benefitted most often and most 
drastically from surgery, (2) patients with large PTBE vol-
umes were most often in poor preoperative condition; in 
our patient cohort, the PTBE volume—not the tumor—was 
the decisive factor determining the patients’ preoperative 
status, and (3) large PTBE volume was not associated with 
treatment-related complications or mortality, as previously 
suggested (Supplementary Table 5) [4, 6–8, 10, 12, 14–16]. 
Rather, they were associated with an increased potential of 
benefitting from surgery [4–8, 10, 12, 14–16].
Thus far, only a few studies have focused on the influ-
ence of PTBE volume on patients’ outcome (Supplemen-
tary Table 5) [4–8, 10, 12, 14–16]. The majority of these 
studies concluded that an increased PTBE was associated 
with poor outcome [4–8, 10, 12, 14–16]. Two studies also 
reported that PTBE was correlated with an increased corti-
cal meningioma infiltration [14, 15]. Since total resection of 
infiltrating meningiomas is likely to cause focal lesions, this 
could partially explain the increased risk of worse outcome. 
In our study, very old meningioma patients were selected for 
surgery mostly when symptomatic. The symptoms appeared 
often to be related to PTBE. Therefore, patients with large 
PTBEs were frequently in poor condition preoperatively, but 
Fig. 2  Tumor and PTBE volumes stratified by preoperative subgroups
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as soon as the PTBE-caused tumor was totally or partially 
removed, their clinical status improved. This postoperative 
improvement occurred rather quickly, namely within the first 
postoperative weeks or months (Fig. 3). Given that there is 
more room for improvement in patients with poor preop-
erative KPS than patients with no or only few preoperative 
symptoms, it is conceivable that even in the case of resec-
tion-related focal brain lesions, very old and symptomatic 
patients with large PTBE volumes are still likely to benefit 
from surgery. Therefore, even if the tumor infiltrates the 
edematous brain, the surgical outcome can be beneficial 
from a patient’s perspective.
Table 2  Decision support tool and outcome
Clinical outcome at 3 months—patients
Improved (%)a 26 (41)
Stable (%)a 11 (17)
Deteriorated (%)a 26 (41)
90-days mortality (%) 10 (14)
Clinical outcome at last follow-up within the first 12 months—patients
Improved (%) 33 (46)
Stable (%) 16 (22)
Deteriorated (%) 23 (32)
Major complications (%) 21 (29)
1-year mortality (%) 11 (15)
Clinical outcome at 3 months—classes
Class A (n = 11) Class B (n = 25) Class C 
(n = 27)
Improved (%)a 3 (27) 6 (24) 17 (63)
Stable (%)a 3 (27) 6 (24) 2 (7)
Deteriorated (%)a 5 (46) 13 (52) 8 (30)
90-days mortality (%) 1 (9) 5 (17) 4 (13)
Clinical outcome at last follow-up within the first 12 months—classes
Class A (n = 11) Class B (n = 30) Class C 
(n = 31)
Improved (%) 2 (18) 11 (37) 20 (65)
Stable (%) 5 (46) 7 (23) 4 (13)
Deteriorated (%) 4 (36) 12 (40) 7 (23)
1-year mortality (%) 1 (9) 6 (20) 4 (13)
Major complications (%) 1 (9) 12 (40) 8 (26)
Mean KPS change (SD) 15 (26) 15 (32) 17 (27)
Median KPS change (range) 0 (10–20) 0 (0–70) 10 (0–60)
Mean KPS improvement (SD) 15 (7) 15 (6) 30 (16)
Median KPS improvement (range) 15 (10–20) 20 (10–50) 20 (10–60)
Correlation analyses—classes
Factor p value
Clinical outcome at 3 months 0.044




The bold lines indicate the subheadings and significant p-values
KPS Karnofsky Performance Scale, SD standard deviation
a Follow-up data not available for all patients
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Our simple KPS and PTBE-based classification may 
help to identify those patients who have the highest likeli-
hood of benefitting from surgery. Previously, the use of the 
SKALE (Sex, KPS, American Society of Anesthesiology 
(ASA) Class, Location of Tumor, and Peritumoral Edema) 
grading system has been suggested to predict surgery-related 
mortality in very old meningioma patients [7, 12]. The 
SKALE system includes five independent parameters (Sex, 
KPS, ASA, Location, Edema), and the total score ranges 
from 0 to 18 [7, 12]. It has been found that lower SKALE 
scores were associated with 1-year mortality [7, 12]. The 
authors concluded that surgery should be deemed reason-
able only for old patients (≥ 80 years) with a score of ≥ 8 
[12]. Although the SKALE system may appear similar to our 
proposed classification system, there are several important 
differences. First, both of the earlier studies used mortality 
as their outcome measure, whereas we aimed to identify 
patients with a potential to improve from surgery [7, 12]. 
When we applied the SKALE system to our patients, only 
39 (54%) had a score of ≥ 8. In other words, if the SKALE 
system had been followed, 33 (46%) of our patients would 
not have been operated on. Of these 33 patients, eight died, 
19 (58%) improved (KPS) and another six (18%) showed 
an unchanged status during the first postoperative year. 
Whether these eight deaths could have been avoided by 
abandoning surgery is debatable, as the natural history of 
symptomatic meningiomas in this age group is unknown. 
Also, even though the patients with a SKALE score of < 8 
were more likely to die within the first year of surgery (8/33 
vs. 3/39, p = 0.052, Chi-squared), the accuracy of predicting 
mortality within the first year after surgery was only 61%, 
and the SKALE score failed to reliably predict neurologi-
cal improvement for our patients (p = 0.478, Chi-squared). 
Moreover, the edema assessment of SKALE is based on con-
ventional axial MRI measurements, and does not include 
volumetric data. In order to more reliably factor PTBE vol-
ume in as a parameter for treatment decision-making and 
risk assessments in meningioma patients, we believe that 
semi-automatic and fully automatic volume-based assess-
ments may increase the reliability and standardize these 
measurements. By using neuronavigation software volumet-
ric assessments were easy and feasible. This widely usable 
approach could help to standardize volume measurements.
Nearly two-thirds of the Class C patients had a func-
tional benefit from surgery. Hence, our decision support 
tool, which is easy to use and can therefore be effortlessly 
applied, may help to form a shared treatment decision with 
the patients and their relatives. For old, symptomatic men-
ingioma patients, it is perhaps more important to estimate 
the likelihood of benefitting than the likelihood of death, 
as quality of life and life expectancy in these patients are 
already compromised. However, our results are preliminary; 
in order to establish the proposed classification, further ret-
rospective or even prospective studies are required.
Our study has several limitations. First, this type of ret-
rospective study inherently includes a selection bias. Those 
patients with larger PTBEs and associated symptoms are 
more likely to be recommended for surgery. Thus, no conclu-
sions with regard to asymptomatic patients may be drawn. In 
fact, in our series of very old meningioma patients, only five 
(7%) were asymptomatic prior to surgery. Moreover, uniden-
tified factors may have further contributed to the selection 
bias. Second, the follow-up was not standardized, as our 
routine follow-up protocol was not applied as rigorously as 
usual. However, we were able to collect the outcome data for 
all patients. As we only evaluated the KPS and mortality, the 
follow-up data is perhaps sufficient and reliable. Third, post-
operative MRI was not available for all patients. Therefore, 
we could not objectively assess the extent of resection. Based 
on operation notes, total resection was achieved in 80% of 
the cases, which equals the MRI findings of those 58% of 
patients with postoperative MRI. Total resection, however, 
is not necessarily the primary goal in very old meningioma 
patients. Similarly, studying meningioma recurrence in this 
Fig. 3  Class and postoperative outcome
116 Journal of Neuro-Oncology (2020) 148:109–116
1 3
aged patient population may have little relevance. Fourth, 
due to the cohort size, negative results (i.e. no associations) 
need to be cautiously interpreted. Fifth, no proper cognitive 
assessments were done prior to and after surgery, although 
40% of patients were operated based on the assumption that 
the meningioma related to cognitive symptoms. We believe 
that this is an important aspect to be addressed in future 
studies, as the factors behind cognitive symptoms in elderly 
can be diverse. In some cases, a cortical biopsy for dementia 
in local anesthesia prior to a major surgery could possibly 
aid in decision-making. Of the 29 patients with suspected 
meningioma-related cognitive symptoms, twelve (41%) 
improved in KPS.
Conclusions
Old meningioma patients with large PTBE usually had a 
poor preoperative performance status, but appeared to ben-
efit most often and most drastically from surgery. Contrary 
to previous studies, large PTBE volumes were not associ-
ated with higher complications rates or mortality [4, 6–8, 
10, 12, 14–16]. Thus, even patients with poor performance 
status could benefit from surgery. We developed a simple, 
patient-centered decision support tool, which may help to 
identify patients with the highest potential for postoperative 
improvement.
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